NCIt definition : A preparation of autologous, dominant-negative receptor (DNR)-expressing nasopharyngeal
carcinoma (NPC)-specific cytotoxic T-lymphocytes (CTLs), with potential antineoplastic
activity. The DNR-expressing NPC-specific CTLs specifically target Epstein-Barr virus
(EBV) nuclear antigen 1 (EBNA1), latent membrane proteins (LMP) and BamHIA rightward
frame 1 (BARF1), and are transduced with a retroviral vector expressing DNR, a dominant-negative
form of the transforming growth factor beta (TGFb) receptor, which blocks TGF-beta-mediated
signaling. Upon administration, the CTLs recognize and target NPC cells, which may
result in both CTL-mediated cell lysis and the inhibition of tumor cell proliferation.
Tumor-expressed TGF-beta inhibits T-lymphocyte activation and expansion; resistance
to TGF-beta allows for optimal CTL activity. EBV infection plays a key role in NPC
tumorigenesis.;